LBRX – lb pharmaceuticals inc (US:NASDAQ)
Stock Stats
News
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
LB Pharmaceuticals Inc (LBRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
LB Pharmaceuticals Highlights LB-102 Phase 3 Schizophrenia Path, Funding Runway to 2029 at Needham [Yahoo! Finance]
LB Pharmaceuticals (LBRX) is now covered by Craig Hallum. They set a "buy" rating and a $36.00 price target on the stock.
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Form ARS LB PHARMACEUTICALS INC For: Dec 31
Form DEF 14A LB PHARMACEUTICALS INC For: Jun 03
Form DEFA14A LB PHARMACEUTICALS INC
Form EFFECT LB PHARMACEUTICALS INC
Form 424B3 LB PHARMACEUTICALS INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.